SCHEMBL8095024

SCHEMBL8095024

O=C(Nc1ccc(Cl)cc1)NS(=O)(=O)C1CCCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
ALDH1A1 P00352 3/20 0.60
EPHX1 P07099 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
KMT2A Q03164 4/20 0.49
HTT P42858 2/20 0.48
POLB P06746 1/20 0.48
MEN1 O00255 3/20 0.48
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
NPSR1 Q6W5P4 1/20 0.46
HPGD P15428 1/20 0.45
PLAU P00749 1/20 0.44
HPN P05981 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083387 0.98 RAB9A (0.57) RAB9ANPC1ALDH1A1EPHX1CYP2C9
SCHEMBL8089942 0.97 RAB9A (0.56) RAB9ANPC1ALDH1A1EPHX1CYP2C9
SCHEMBL6466718 0.85 EPHX1 (0.58) RAB9AALDH1A1EPHX1SMN1; SMN2KMT2A
SCHEMBL6465976 0.84 MEN1 (0.49) RAB9ANPC1ALDH1A1EPHX1CYP2C9
SCHEMBL8091213 0.84 RAB9A (0.57) RAB9ANPC1EPHX1SMN1; SMN2KMT2A
SCHEMBL8091184 0.84 RAB9A (0.57) RAB9ANPC1EPHX1SMN1; SMN2KMT2A
SCHEMBL8095056 0.83 EPHX2 (0.54) RAB9ANPC1ALDH1A1EPHX1CYP2C19
SCHEMBL8095054 0.83 EPHX2 (0.54) RAB9ANPC1ALDH1A1EPHX1CYP2C19
SCHEMBL19505872 0.83 ACP1 (0.57) RAB9AALDH1A1EPHX1CYP2C9SMN1; SMN2
SCHEMBL8089968 0.83 EPHX2 (0.57) RAB9ANPC1ALDH1A1EPHX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US claimed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP claimed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP claimed
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed